HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Secretory phospholipase A(2) in newborn infants with sepsis.

AbstractOBJECTIVE:
To investigate secretory phospholipase A(2) (sPLA(2)) activity in neonatal sepsis.
STUDY DESIGN:
Plasma sPLA(2) activity, C-reactive protein (CRP) concentration, leukocyte count and immature/total neutrophil (I/T) ratio were assessed in a group of 156 infants admitted for neonatal intensive care, who were classified as documented sepsis (n=24), suspected infection (n=77) and controls (n=55). Interleukin-6 (IL-6) concentrations were assessed in a subgroup (n=29).
RESULT:
sPLA(2) activity, CRP concentration and I/T ratio were higher in sepsis than in suspected infection or control groups. sPLA(2) activity advanced with increasing CRP, I/T ratio and IL-6 was highest in infants with respiratory distress syndrome (RDS). Compared to CRP, sPLA(2) had equal sensitivity and lower specificity. Compared to I/T ratio, sensitivity and specificity of sPLA(2) were higher.
CONCLUSION:
Plasma sPLA(2) activity is increased in neonatal sepsis and highest in infants with RDS. Further studies should assess the potential of sPLA(2) inhibition in neonatal sepsis.
AuthorsA J J Schrama, A J de Beaufort, B J H M Poorthuis, H M Berger, F J Walther
JournalJournal of perinatology : official journal of the California Perinatal Association (J Perinatol) Vol. 28 Issue 4 Pg. 291-6 (Apr 2008) ISSN: 0743-8346 [Print] United States
PMID18200020 (Publication Type: Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • C-Reactive Protein
  • Phospholipases A2, Secretory
Topics
  • C-Reactive Protein (metabolism)
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases (blood, diagnosis, enzymology)
  • Interleukin-6 (blood)
  • Leukocyte Count
  • Male
  • Neutrophils
  • Phospholipases A2, Secretory (blood)
  • Predictive Value of Tests
  • Sepsis (blood, diagnosis, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: